NWL:NASDAQNewell Brands Inc. Analysis
Data as of 2026-04-21 - not real-time
$4.28
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Newell Brands is trading below its 200‑day moving average, with the 20‑day SMA sitting under the 50‑day SMA, signaling a lingering bearish bias. The RSI hovers in the low‑60s, suggesting momentum is still positive but not yet overbought. A bullish MACD histogram provides a hint of short‑term upside, while the price remains comfortably above the identified support level and well under the resistance ceiling. The stock’s forward P/E of roughly 6.5 and a price‑to‑book under 1.0 point to a valuation that appears attractive relative to peers. However, the dividend yield of over 6% is backed by a payout ratio well above 100%, raising questions about its durability. Recent corporate communications tout the “One Newell” integration effort aimed at streamlining operations and driving growth, which could improve margins if executed well.
Fundamentally, the company reports negative trailing earnings, a modest operating margin, and a high debt‑to‑equity ratio that exceeds 200%, underscoring balance‑sheet pressure. Free cash flow is positive, but operating cash flow remains limited, and the ROE is negative, reflecting profitability challenges. Volatility is elevated at more than 50% over the past month, and beta is close to 2, indicating sensitivity to market swings. Analyst consensus leans toward a “hold” stance with a median price target modestly above the current level, implying limited upside expectations. The confluence of an undervalued price, high dividend yield, and ongoing restructuring creates a mixed outlook that warrants cautious positioning.
Fundamentally, the company reports negative trailing earnings, a modest operating margin, and a high debt‑to‑equity ratio that exceeds 200%, underscoring balance‑sheet pressure. Free cash flow is positive, but operating cash flow remains limited, and the ROE is negative, reflecting profitability challenges. Volatility is elevated at more than 50% over the past month, and beta is close to 2, indicating sensitivity to market swings. Analyst consensus leans toward a “hold” stance with a median price target modestly above the current level, implying limited upside expectations. The confluence of an undervalued price, high dividend yield, and ongoing restructuring creates a mixed outlook that warrants cautious positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish longer‑term moving averages
- Bullish MACD histogram
- Support level cushioning downside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Attractive valuation multiples
- Potential margin improvement from One Newell initiative
- Positive free cash flow despite earnings loss
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High debt burden limiting financial flexibility
- Unsustainable dividend payout ratio
- Consumer defensive sector providing defensive cushion
Key Metrics & Analysis
Financial Health
Revenue Growth-2.70%
Profit Margin-3.96%
P/E Ratio6.4
ROE-11.09%
ROA2.81%
Debt/Equity226.47
P/B Ratio0.7
Op. Cash Flow$264.0M
Free Cash Flow$350.4M
Technical Analysis
TrendBearish
RSI61.9
Support$3.27
Resistance$4.48
MA 20$3.78
MA 50$4.10
MA 200$4.57
MACDBullish
VolumeIncreasing
Fear & Greed Index86.86
Valuation
Target Price$4.78
Upside/Downside11.84%
GradeUndervalued
TypeBlend
Dividend Yield6.41%
Risk Assessment
Beta1.92
Volatility53.58%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.